ES Kang, SY Park, HJ Kim, CW Ahn, M Nam, BS … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS —Regarding SNP45, there was a smaller reduction in the fasting plasma glucose
(FPG) level and the HbA 1c value in the carriers of the GG genotype than in the carriers of the
other genotypes (P = 0.031 and 0.013, respectively). There was a smaller increase in the ... Cited by 53 - Related articles - All 9 versions
- ►diabetesjournals.org ES Kang, BS Cha, HJ Kim, HJ Kim, SH Kim, KY Hur … - Diabetes care, 2006 - Am Diabetes Assoc RESULTS—Although fasting plasma glucose and HbA 1c levels decreased; mean body weight
increased significantly after rosiglitazone treatment. Among the four SNPs tested, only the PLIN
11482G>A polymorphism was associated with weight gain from rosiglitazone treatment. ... Cited by 22 - Related articles - BL Direct - All 7 versions
ES Kang, SY Park, HJ Kim, CS Kim, CW Ahn, … - Clinical pharmacology …, 2005 - 134.68.189.85 Objective: The aim of this study was to examine the effects of the Pro12Ala polymorphism of the
peroxisome proliferator–activated receptor (PPAR) 2 gene on the response to rosiglitazone in
patients with type 2 diabetes mellitus. Methods: A total of 198 patients with type 2 ... Cited by 33 - Related articles - View as HTML - All 8 versions
M Blüher, G Lübben, R Paschke - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 131 patients were treated in an
open-label, randomized, multicenter study with pioglitazone (45 mg od) during a course of
≥26 weeks. Response to the pioglitazone therapy was defined by either a >20% ... Cited by 43 - Related articles - BL Direct - All 5 versions
G Wang, X Wang, Q Zhang, Z Ma - International Journal of …, 2007 - interscience.wiley.com To investigate the influence of the S447X variant in lipoprotein lipase (LPL) gene on the response
rate to therapy with the thiazolidinedione pioglitazone. A total of 113 diabetic patients were treated
with pioglitazone 30 mg for 10 weeks. Response to the pioglitazone treatment was ... Cited by 11 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org S Snitker, RM Watanabe, I Ani, AH Xiang, A … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—The mean changes in S i in the bottom, middle, and top tertiles of S i response were
−0.21 ± 0.57, 0.91 ± 0.26, and 2.58 ± 1.32 min −1 per μU/ml · 10 −4 , respectively. Frequencies
of the Ala/− genotype were 30, 22, and 26% in the same three tertiles (P = 0.77). Analysis ... Cited by 40 - Related articles - BL Direct - All 5 versions
JK Wolford, KA Yeatts, SK Dhanjal, MH Black, AH … - Diabetes, 2005 - Am Diabetes Assoc Thiazolidinediones (TZDs) are peroxisome proliferator–activated receptor-γ (PPARG) agonists
used to treat type 2 diabetes. TZDs can also be used to reduce rates of type 2 diabetes in at-risk
individuals. However, a large fraction of TZD-treated patients (30–40%) do not respond to ... Cited by 31 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org J Zacharova, JL Chiasson, M Laakso - Diabetes, 2005 - Am Diabetes Assoc Adiponectin is an adipose tissue-specific protein with insulin-sensitizing and antiatherogenic
properties. Therefore, the adiponectin gene is a promising candidate gene for type 2
diabetes. We investigated the single nucleotide polymorphisms (SNPs) +45T/G and ... Cited by 57 - Related articles - All 5 versions
C Populaire, Y Mori, C Dina, F Vasseur, M Vaxillaire, T … - Diabetologia, 2003 - Springer The number of hospitalised infections in first year of life were also analysed for interaction with
gender. This showed no difference between boys and girls (p=0.94). To our knowledge this is
the first study indicating a gender difference in the impact of neonatal infections on the ... Cited by 37 - Related articles - All 3 versions
YM Kim, BS Cha, DJ Kim, SH Choi, SK Kim, CW … - Diabetes research and …, 2005 - Elsevier This study evaluated the efficacy of rosiglitazone in non-obese and obese Korean type 2 diabetic
patients of long duration. A total of 125 patients (M:F = 44:81, mean age: 58.4 ± 9.1 years,
BMI: 24.2 ± 2.7 kg/m 2 , duration of diabetes: 11.0 ± 6.4 years) were randomly allocated to ... Cited by 14 - Related articles - All 9 versions
